Selected article for: "characteristic curve and CSF concentration"

Title: 2016 ACVIM Forum Research Abstract Program
  • Document date: 2016_5_31
  • ID: 2y1y8jpx_114
    Snippet: Using an enzyme-linked immunosorbent assay (ELISA), we measured pNF-H concentration in CSF from aged control dogs (n = 10) and DM-affected dogs at all stages (stage 1 n = 9; stage 2 n = 6; stage 3 n = 6; stage 4 n = 3). Data were analyzed using Kruskal-Wallis ANOVA on ranks with post-hoc Dunn's method. Additionally, CSF pNF-H concentration was compared between DM-affected dogs (n = 24) and dogs with other chronic spinal cord disease (n = 7). Thos.....
    Document: Using an enzyme-linked immunosorbent assay (ELISA), we measured pNF-H concentration in CSF from aged control dogs (n = 10) and DM-affected dogs at all stages (stage 1 n = 9; stage 2 n = 6; stage 3 n = 6; stage 4 n = 3). Data were analyzed using Kruskal-Wallis ANOVA on ranks with post-hoc Dunn's method. Additionally, CSF pNF-H concentration was compared between DM-affected dogs (n = 24) and dogs with other chronic spinal cord disease (n = 7). Those data were analyzed by the student's t test. To evaluate diagnostic performance, a receiver operating characteristic curve was generated.

    Search related documents:
    Co phrase search for related documents
    • characteristic curve and diagnostic performance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • characteristic curve and diagnostic performance evaluate: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • characteristic curve and ELISA immunosorbent assay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • characteristic curve and immunosorbent assay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • chronic spinal cord disease and cord disease: 1, 2, 3
    • cord disease and ELISA immunosorbent assay: 1
    • cord disease and immunosorbent assay: 1
    • diagnostic performance and ELISA immunosorbent assay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • diagnostic performance and immunosorbent assay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • diagnostic performance evaluate and ELISA immunosorbent assay: 1, 2, 3
    • diagnostic performance evaluate and immunosorbent assay: 1, 2, 3
    • ELISA immunosorbent assay and enzyme link: 1
    • ELISA immunosorbent assay and enzyme link ELISA immunosorbent assay: 1
    • ELISA immunosorbent assay and immunosorbent assay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • enzyme link and immunosorbent assay: 1, 2
    • enzyme link ELISA immunosorbent assay and immunosorbent assay: 1